Skip to main content
. 2015 Oct 16;6(39):42372–42379. doi: 10.18632/oncotarget.5713

Table 3. Clinical characteristics.

Variables n (%)
Gender
 Male 80 77.7
 Female 23 22.3
Age (year)
 median 59
 range 21–80
ECOG
 0 38 36.9
 1 65 63.1
Hepatitis
 None 2 1.9
 HBV 73 70.9
 HCV 9 8.7
 Others 19 18.4
Liver cirrhosis
 No 32 31.1
 Yes 71 68.9
AFP (IU/mL)
 ≤400 67 65.0
 >400 36 35.0
Child-Pugh score before RT
 A5 61 59.2
 A6 30 29.1
 B7 12 11.7
TNM stage
 II 14 13.6
 III 81 78.6
 IVA 8 7.8
Previous treatment
 None 7 6.8
 TACE 95 92.2
 RFA 8 7.8
 PEI 8 7.8
 Chemotherapy 14 13.6

Abbreviations: ECOG PS = Eastern Cooperative Oncology Group performance status; HBV = hepatitis B virus; HCV = hepatitis C virus; PVTT = portal vein tumor thrombosis; AFP = alpha-fetoprotein; TACE = transcarterial chemoembolization; RFA = radiofrequency ablation; PEI = percutaneous ethanol injection